Meeder Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20
| Closed | -$2.64K | – | 1024 |
|
|
2025
Q1 | $2.64K | Sell |
20
-33
| -62% | -$4.35K | ﹤0.01% | 849 |
|
|
2024
Q4 | $4.43K | Buy |
+53
| New | +$4.43K | ﹤0.01% | 846 |
|
|
2024
Q3 | – | Sell |
-47
| Closed | -$3.22K | – | 979 |
|
|
2024
Q2 | $3.22K | Sell |
47
-37
| -44% | -$2.53K | ﹤0.01% | 819 |
|
|
2024
Q1 | $5.81K | Buy |
+84
| New | +$5.81K | ﹤0.01% | 620 |
|
|
2022
Q3 | – | Sell |
-367
| Closed | -$21K | – | 2412 |
|
|
2022
Q2 | $21K | Buy |
+367
| New | +$21K | ﹤0.01% | 1137 |
|
|
2021
Q3 | – | Sell |
-1,700
| Closed | -$69K | – | 2672 |
|
|
2021
Q2 | $69K | Buy |
+1,700
| New | +$69K | ﹤0.01% | 1025 |
|
|
2020
Q4 | – | Sell |
-1,582
| Closed | -$41K | – | 2279 |
|
|
2020
Q3 | $41K | Buy |
+1,582
| New | +$41K | ﹤0.01% | 994 |
|
|
2020
Q2 | – | Sell |
-423
| Closed | -$7K | – | 2539 |
|
|
2020
Q1 | $7K | Sell |
423
-313
| -43% | -$5.18K | ﹤0.01% | 1676 |
|
|
2019
Q4 | $26K | Sell |
736
-409
| -36% | -$14.4K | ﹤0.01% | 1271 |
|
|
2019
Q3 | $9K | Sell |
1,145
-733
| -39% | -$5.76K | ﹤0.01% | 1582 |
|
|
2019
Q2 | $24K | Buy |
1,878
+1,566
| +502% | +$20K | ﹤0.01% | 1177 |
|
|
2019
Q1 | $4K | Sell |
312
-427
| -58% | -$5.47K | ﹤0.01% | 1459 |
|
|
2018
Q4 | $8K | Buy |
+739
| New | +$8K | ﹤0.01% | 1311 |
|
|
2017
Q3 | – | Sell |
-149
| Closed | -$2K | – | 1788 |
|
|
2017
Q2 | $2K | Sell |
149
-599
| -80% | -$8.04K | ﹤0.01% | 1438 |
|
|
2017
Q1 | $12K | Sell |
748
-1,268
| -63% | -$20.3K | ﹤0.01% | 821 |
|
|
2016
Q4 | $30K | Buy |
+2,016
| New | +$30K | ﹤0.01% | 610 |
|
|
2016
Q2 | – | Sell |
-3,574
| Closed | -$99K | – | 972 |
|
|
2016
Q1 | $99K | Buy |
+3,574
| New | +$99K | 0.01% | 698 |
|